Abstract

Patients with end-stage renal disease have a high prevalence of cardiovascular disease. Chest radiography can be used to assess cardiothoracic ratio (CTR) and aortic arch calcification (AoAC). The aims of this longitudinal follow-up study were to investigate factors associated with changes in CTR and AoAC and understand whether these changes are associated with overall and cardiovascular mortality in hemodialysis (HD) patients. We enrolled 260 patients undergoing HD who had at least two available chest X-rays from 2008 to 2015. CTR and AoAC were assessed in each patient using measurements from baseline and annual chest X-rays. The CTR increased from 49.05% to 51.86% and the AoAC score increased from 3.84 to 9.73 over 7 years. The estimated slopes were 0.24 (p < 0.0001) for CTR and 0.08 (p = 0.0441) for AoAC. Increased AoAC, older age, female sex, coronary artery disease, and decreased albumin were associated with an increase in CTR, and older age, cerebrovascular disease, decreased albumin, increased Kt/V, and the use of antiplatelet agents were associated with an increase in AoAC. During follow-up, 136 of the 260 (52.3%) patients died, of whom 72 died due to cardiovascular causes. The change in CTR was greater in those who died (p = 0.0125) than in those who survived. The AoAC score was also higher in those who died than in those who survived, although there was no significant difference in the change in AoAC between the two groups (p = 0.8035). CTR and AoAC increased significantly over time in the HD patients in this longitudinal follow-up study, and the change in CTR was greater in those who died than in those who survived. Chest radiography is a simple and useful tool to assess the progression of CTR and AoAC as a prognostic marker.

Highlights

  • Cardiovascular disease is the leading cause of mortality in patients with end-stage renal disease (ESRD), accounting for 43% of all deaths [1]

  • We demonstrated that cardiothoracic ratio (CTR) increased significantly over time in patients undergoing HD, and that the change in CTR was greater in those who died than in those who survived

  • aortic arch calcification (AoAC) significantly increased over time, and the AoAC score was higher in those who died than in those who survived, there was no significant difference in the change in AoAC between the two groups

Read more

Summary

Introduction

Cardiovascular disease is the leading cause of mortality in patients with end-stage renal disease (ESRD), accounting for 43% of all deaths [1]. A 4-year cohort study suggested an association between a high baseline CTR and increased overall mortality and cardiovascular events [3]. Several studies have demonstrated that aortic arch calcification (AoAC) can be used to predict cardiovascular events and overall mortality in dialysis patients [5,6,7]. Vascular calcification can be detected using various imaging modalities, including plain radiography, computed tomography (CT), sonography, magnetic resonance imaging, and 18F-fluoride positron emission tomography [8]. Of these modalities, chest radiography is non-invasive and widely available, and it can be used to evaluate both CTR and AoAC

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call